At Center for Breakthrough Medicines, our mission is to save lives by accelerating the development and manufacturing of advanced therapies.
Our fully integrated services include drug substance and drug product for all phases of the product lifecycle at a single site.
Center for Breakthrough Medicines Amplifies Viral Vector Manufacturing Capabilities by Licensing Asimov’s High-Performance GMP Suspension HEK293 PlatformJanuary 18, 2023
Autolomous LTD, the market-leading developer of critical manufacturing management systems for Cell and Gene Therapies (CGT), today announced a license agreement with U.S.-based Center for Breakthrough Medicines (CBM) a cell and gene therapy contract development, manufacturing, and testing organization (CDMO).January 12, 2023
End-to-End Manufacturing at a Single Site and High-throughput Vector Suite Design Will Bolster Batch Production Up to Five TimesDecember 8, 2022
The Center for Breakthrough Medicines (CBM), announced today the launch of their Analytical AcceleratorTM for AAV Testing to help gene therapy developers meet the quality domains of identity, safety, purity, potency, and stability required by the Food and Drug Administration (FDA) and global regulatory authorities.October 19, 2022
Center for Breakthrough Medicines and jCyte Announce Strategic Partnership to Manufacture jCyte’s Innovative Cell Therapy for Treatment of Retinal Degenerative Diseases.September 20, 2022
Our empowering culture supports people committed to transforming patients’ lives.Learn More >
CBM is led by an amazing team. Discover the caliber of people you will work with.Learn more >